Ophthalmologic and intraocular non-Hodgkin's lymphoma: A large single centre study of initial characteristics, natural history, and prognostic factors

Hematological Oncology

Volumn 22, Issue 4, 2004, Pages 143-158

  Meunier, Jéreôme ^a   Lumbroso Le Rouic, Livia ^a   Vincent Salomon, Anne ^a   Dendale, Rémy ^a   Asselain, Bernard ^a   Arnaud, Philippe ^a   Fourquet, Alain ^a   Desjardins, Laurence ^a   Plancher, Corine ^a   Validire, Patricia ^a   Chaoui, Driss ^a   Lévy, Christine ^a   Decaudin, Didier ^a  

^a INSTITUT CURIE   (France)

Author keywords

Non Hodgkin's lymphoma; Ocular and adnexal localization

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; LMP 89; PREDNISONE; UNCLASSIFIED DRUG; VINCRISTINE;

B CELL LYMPHOMA; BREAST CANCER; BURKITT LYMPHOMA; CANCER STAGING; CATARACT; CHEMOTHERAPY; CLINICAL FEATURE; FOLLICULAR LYMPHOMA; FOLLOW UP; HISTOLOGY; HUMAN; INTRAOCULAR TUMOR; LARGE CELL LYMPHOMA; LYMPHOCYTOMA; MANTLE CELL LYMPHOMA; METASTASIS; POPULATION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; SKIN CARCINOMA; T CELL LYMPHOMA; WORLD HEALTH ORGANIZATION; XEROPHTHALMIA;

ADULT; AGED; DISEASE-FREE SURVIVAL; EYE NEOPLASMS; FEMALE; FRANCE; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, HIGH-GRADE; LYMPHOMA, LOW-GRADE; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 25144493178     PISSN: 02780232     EISSN: None     Source Type: Journal    
DOI: 10.1002/hon.741     Document Type: Review

References (38)

1. Feinstein AR, Krause AC. Ocular involvement in lymphomatous disease. Am Arch Ophthalmol 1952; 48: 328-337.
2. Fitzpatrick PJ, Macko S. Lymphoreticular tumors of the orbit, Int J Radiat Oncol Biol Phys 1984; 10: 333-340.
3. Lambo MJ, Brady LW, Shields CL. Lymphoid tumors of the orbit. In Radiotherapy of Intraocular and Orbital Tumors, Alberti WE, Sagerman RH (eds). Springer-Verlag: Berlin, 1993; 205-216.
4. Margo CE, Mulla ZD. Malignant tumors of the orbit. Analysis of the Florida Cancer Registry. Ophthalmology 1998; 105: 185-190.
5. Harris NL, Jaffe ES, Diébold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835-3849.
6. Oken MM, Creech RH, Tormay DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-655.
7. Carbone PP, Kaplan HS, Musshoff K, et al. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971; 31: 1860-1861.
8. Shipp MA, Harrington DP, Anderson JR, et al. A predictive model for aggressive non-Hodgkin's lymphoma: the international non-Hodgkin's lymphoma prognostic factors project. N Engl J Med 1993; 329: 987-994.
9. Patte C, Auperin A, Michon J, et al. The société française d'oncologie pédiatrique LMB 89 protocol: highly effective multiagent chemotherapy tailored too the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemias. Blood 2001; 97: 3370-3379.
10. Cheson BD, Horning JS, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. J Clin Oncol 1999; 17: 1244-1253.
11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
12. Cox DR. Regression models and life tables. J Roy Stat Soc 1972; 34: 187-220.
13. Bessell EM, Henk JM, Wright JE, et al. Orbital and conjunctival lymphoma treatment and prognosis. Radiother Oncol 1988; 13: 237-244.
14. White WL, Ferry JA, Harris NL, et al. Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type. Ophthalmology 1995; 102: 1994-2006.
15. Esik O, Ikeda H, Mukai K, et al. A retrospective analysis of different modalities for treatment of primary orbital non-Hodgkin's lymphomas. Radiother Oncol 1996; 38: 13-18.
16. Restrepo A, Raez LE, Byrne GE Jr, et al. Is central nervous system prophylaxis necessary in ocular adnexal lymphoma? Crit Rev Oncog 1998; 9: 269-273.
17. Nakata M, Matsumo Y, Katsumata N, et al. Histology according to the Revised European-American Lymphoma classification significantly predicts the prognosis of ocular adnexal lymphoma. Leuk Lymph 1999; 32: 533-543.
18. Jenkins C, Rose GE, Bunce C, et al. Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival. Br J Ophthalmol 2000; 84: 907-913.
19. Auw-Haedrich C, Coupland SE, Kapp A, et al. Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Br J Ophthalmol 2001; 85: 63-69.
20. Bhatia S, Paulino AC, Buatti JM, et al. Curative radiotherapy for primary orbital lymphoma. Int J Radiat Oncol Biol Phys 2002; 54: 818-823.
21. Cho EY, Han JJ, Ree HJ, et al. Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone B-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients. Am J Hematol 2003; 73: 87-96.
22. Fung CY, Tarbell NJ, Lucarelli MJ, et al. Ocular adnexal lymphoma: clinical behavior of distinct WHO classification subtypes. Int J Radiat Oncol Biol Phys 2003; 57: 1382-1391.
23. Jenkins C, Rose GE, Bunce C, et al. Clinical features associated with survival of patients with lymphoma of the ocular adnexa. Eye 2003; 17: 809-820.
24. Martinet S, Ozsahin M, Belkacemi Y, et al. Outcome and prognostic factors in orbital lymphoma: a rare cancer network study on 90 consecutive patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 2003; 55: 892-898.
25. Uno T, Isobe K, Shikama N, et al. Radiotherapy for extranodal, marginal-zone, B-cell lymphoma of Mucosa-Associated Lymphoid Tissue originating in the ocular adnexa. Cancer 2003; 98: 865-871.
26. 1 gene rearrangement in ocular adnexal MALT lymphoma. Pathol Intern 2004; 54: 16-25.
27. Coupland SE, Hellmich M, Auw-Haedrich C, et al. Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases. Graefes Arch Clin Exp Ophthalmol 2004; 242: 130-145.
28. Zucca E, Roggero E, Pinotti G, et al. Patterns of survival in mantle cell lymphoma. Ann Oncol 1995; 6: 257-262.
29. Glass AG, Karnell LH, Menck HR. Data base report on non-Hodgkin's lymphoma. Cancer 1997; 80: 2311-2320.
30. Thieblemont C, Berger F, Dumontet C. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 2000; 95: 802-806.
31. Tsang RW, Gospodarowicz MK, Pintilie M, et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol 2003; 21: 4157-4164.
32. Zucca E, Conconi A, Pedrinis E. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 2003; 101: 2489-2495.
33. Bolek TW, Moyses HM, Marcus RB, et al. Radiotherapy in the management of orbital lymphoma. Int J Radiat Oncol Biol Phys 1999; 44: 31-36.
34. Coupland SE, Krause L, Delecluse HJ, et al. Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases. Ophthalmology 1998; 105: 1430-1441.
35. Stafford SL, Koselsky TF, Garrity JA, et al. Orbital lymphoma: radiotherapy outcome and complications. Radiother Oncol 2001; 59: 139-144.
36. Akpek EK, Ahmed I, Hochberg FH, et al. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology 1999; 106: 1805-1810.
37. Ferreri AJ, Guidoboni M, Ponzoni M, et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphoma. J Natl Cancer Inst 2004; 96: 586-594.
38. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, et al. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338: 1175-1176.